Jaydeep S Chauhan, Jigar Vyas, U.M. Upadhyay
firstname.lastname@example.org , email@example.com
Jaydeep S Chauhan1, Jigar Vyas2, U.M. Upadhyay3
1Sigma Institute of Pharmacy, Bakrol Vadodara, Gujarat, India.
2Sigma Institute of Pharmacy, Bakrol Vadodara, Gujarat, India.
3Sigma Institute of Pharmacy, Bakrol Vadodara, Gujarat, India.
Volume - 15,
Issue - 4,
Year - 2023
Introduction: The two key challenges for formulation scientists in developing therapeutic delivery are the dissolution and solubility of a low aqueous-soluble drug. Many powerful drug molecules do not have therapeutic effects owing to solubility concerns, yet they can be dangerous when administered in large dosages. Solid dispersion technology is a good method for increasing solubility and dissolution, along with bioavailability. Material and Methods: solid dispersion of rosuvastatin was developed using casein, infant formula, and poly-ethylene glycol 6000 by conventional fusion method and characterized for several characterization parameters. Conclusion: Solid dispersion of rosuvastatin was efficiently developed. The dissolution of rosuvastatin solid dispersion was discovered to be noticeably increased as compared to rosuvastatin API, according to the current investigation, SD of rosuvastatin was a superior alternative for increasing the dissolution of weakly soluble therapeutic agent.
Cite this article:
Jaydeep S Chauhan, Jigar Vyas, U.M. Upadhyay. Enhancement of water solubility of Poorly Water-soluble drug using milk protein as carrier. Research Journal of Pharmaceutical Dosage Forms and Technology2023; 15(4):236-0. doi: 10.52711/0975-4377.2023.00038
Jaydeep S Chauhan, Jigar Vyas, U.M. Upadhyay. Enhancement of water solubility of Poorly Water-soluble drug using milk protein as carrier. Research Journal of Pharmaceutical Dosage Forms and Technology2023; 15(4):236-0. doi: 10.52711/0975-4377.2023.00038 Available on: https://rjpdft.com/AbstractView.aspx?PID=2023-15-4-3
1 Madan JR, Pawar KT, Dua K., et al. Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy. Int J Pharm Investig. 2015; 5(2):114-120.
2 Singh R, Bharti N, Madan J, Hiremath SN., et al. Characterization of cyclodextrin inclusion complexes - A review. J Pharm Sci Technol. 2010; 2(3):171-183.
3 Madan J, Sudarshan B, Kadam V, Dua K., et al. Formulation and development of self-micro emulsifying drug delivery system of pioglitazone hydrochloride. Asian J Pharm. 2014 ;27-34.
4 Madan JR, Ghuge NP, Dua K., et al. Formulation and evaluation of pro-niosomes containing lornoxicam. Drug Deliv Transl Res. 2016; 6(5):511-518.
5 Madan JR, Khude PA, Dua K., et al. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharma Investing. 2014; 4(2):60-64.
6 Ahuja G, Pathak K., et al. Porous carriers for controlled/modulated drug delivery. Indian J Pharm Sci. 2009; 71(6):599-607.
7 Malinda Salim, Thomas Eason., et al. Opportunities for milk and milk-related systems as ‘new’ low-cost excipient drug delivery materials. Advanced Drug Delivery Reviews. 2022; 183 (2022) 114139.
8 Tiwari R, Pathak K., et al. Statins therapy: A review on conventional and novel formulation approaches. J Pharm Pharmacol. 2011; 63:983-998.
9 Shayanfar A, Ghavimi H, Hamishehkar H, Jouyban A. et al. Coamorphous rosuvastatin calcium to improve its physicochemical and pharmacokinetic properties. J Pharm Sci. 2013; 16(4):577–587.
10 Maheshwari RK, Jagwani Y., et al. Mixed hydrotrophy: Novel science of solubility enhancement. Indian J Pharm Sci.2011; 73: 179-183.
11 Jayakumar C, Morais AP., et al. Solubility enhancement of theophylline drug using different solubilization techniques. International Journal of Pharmaceutical Sciences. 2012; 2: 7-10.
12. Mathews BR., et al. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm. 1999 ;25(7): 831-856.